+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Cardiac Mapping Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025

  • ID: 4995220
  • Report
  • February 2020
  • Region: Global
  • 141 pages
  • 360iResearch
UP TO OFF
until Jul 31st 2020
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott Laboratories
  • Angiodynamics
  • Biosense Webster, Inc.
  • Biotronik
  • EP Solutions Sa
  • Lepu Medical
  • MORE
The Global Cardiac Mapping Market is expected to grow from USD 1,323.45 Million in 2018 to USD 2,486.23 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 9.42%.

The positioning of the Global Cardiac Mapping Market vendors in the FPNV Positioning Matrix are determined by Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinders, N: Niche, and V: Vital).

The report explores the recent significant developments by the leading vendors and innovation profiles in the Global Cardiac Mapping Market including are Abbott Laboratories, Biosense Webster, Inc., Boston Scientific Corporation, Medtronic Plc, Microport Scientific Corporation, Acutus Medical, Angiodynamics, APN Health, LLC, Biosig Technologies, Inc., Biotronik, Coremap, EP Solutions Sa, Koninklijke Philips N.V., and Lepu Medical.

On the basis of Type, the Global Cardiac Mapping Market is examined across Contact Cardiac Mapping System and Non-Contact Cardiac Mapping System.

On the basis of Indication, the Global Cardiac Mapping Market is examined across Atrial Fibrillation, Atrial Flutter, and Atrioventricular Nodal Reentry Tachycardia (Avnrt).

For the detailed coverage of the study, the market has been geographically divided into the Americas, Asia-Pacific, and Europe, Middle East & Africa. The report provides details of qualitative and quantitative insights about the major countries in the region and taps the major regional developments in detail.

In the report, we have covered two proprietary models, the FPNV Positioning Matrix and Competitive Strategic Window. The FPNV Positioning Matrix analyses the competitive market place for the players in terms of product satisfaction and business strategy they adopt to sustain in the market. The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisitions strategies, geography expansion, research & development, new product introduction strategies to execute further business expansion and growth.

Research Methodology:

The market forecasting is based on a market model derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding attained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the Global Cardiac Mapping Market
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the Global Cardiac Mapping Market
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the Global Cardiac Mapping Market
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the Global Cardiac Mapping Market
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the Global Cardiac Mapping Market

The report answers questions such as:

1. What is the market size of the global Cardiac Mapping market?
2. What are the factors that affect the growth in the Global Cardiac Mapping Market over the forecast period?
3. What is the competitive position in the Global Cardiac Mapping Market?
4. Which are the best product areas to be invested in over the forecast period in the Global Cardiac Mapping Market?
5. What are the opportunities in the Global Cardiac Mapping Market?
6. What are the modes of entering the Global Cardiac Mapping Market?
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • Angiodynamics
  • Biosense Webster, Inc.
  • Biotronik
  • EP Solutions Sa
  • Lepu Medical
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research & Forecasting
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology

3. Executive Summary
3.1. Market Outlook
3.2. Market Data Feed

4. Premium Insight
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porters Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Client Customizations

5. Global Cardiac Mapping Market, by Type
5.1. Overview
5.2. Market Sizing & Forecasting
5.3. Contact Cardiac Mapping System
5.3.1. Basket Catheter Mapping System
5.3.2. Electroanatomical Mapping System
5.3.3. Traditional Endocardial Catheter Mapping System
5.4. Non-Contact Cardiac Mapping System

6. Global Cardiac Mapping Market, by Indication
6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Atrial Fibrillation
6.4. Atrial Flutter
6.5. Atrioventricular Nodal Reentry Tachycardia (Avnrt)

7. Global Cardiac Mapping Market, by Geography
7.1. Overview
7.2. Market Sizing & Forecasting
7.3. Americas
7.3.1. Argentina
7.3.2. Brazil
7.3.3. Canada
7.3.4. Chile
7.3.5. Mexico
7.3.6. United States
7.4. Asia-Pacific
7.4.1. Australia
7.4.2. China
7.4.3. India
7.4.4. Indonesia
7.4.5. Japan
7.4.6. Malaysia
7.4.7. Philippines
7.4.8. South Korea
7.4.9. Thailand
7.5. Europe, Middle East & Africa
7.5.1. Denmark
7.5.2. France
7.5.3. Germany
7.5.4. Italy
7.5.5. Netherlands
7.5.6. Qatar
7.5.7. Russia
7.5.8. Saudi Arabia
7.5.9. South Africa
7.5.10. Spain
7.5.11. United Arab Emirates
7.5.12. United Kingdom

8. Competitive Landscape
8.1. FPNV Positioning Matrix
8.1.1. Quadrants
8.1.1.1. Forefront
8.1.1.2. Pathfinders
8.1.1.3. Niche
8.1.1.4. Vital
8.1.2. Business Strategy
8.1.2.1. Business Growth
8.1.2.2. Industry Coverage
8.1.2.3. Financial Viability
8.1.2.4. Channel Support
8.1.3. Product Satisfaction
8.1.3.1. Value for Money
8.1.3.2. Ease of Use
8.1.3.3. Product Features
8.1.3.4. Customer Support
8.2. Market Vendor Ranking Analysis
8.3. Competitive News Feed Analysis

9. Company Usability Profiles
9.1. Abbott Laboratories
9.1.1. Overview
9.1.2. Strategy
9.1.3. SWOT
9.2. Biosense Webster, Inc.
9.2.1. Overview
9.2.2. Strategy
9.2.3. SWOT
9.3. Boston Scientific Corporation
9.3.1. Overview
9.3.2. Strategy
9.3.3. SWOT
9.4. Medtronic Plc
9.4.1. Overview
9.4.2. Strategy
9.4.3. SWOT
9.5. Microport Scientific Corporation
9.5.1. Overview
9.5.2. Strategy
9.5.3. SWOT
9.6. APN Health, LLC
9.7. Acutus Medical
9.8. Angiodynamics
9.9. Biosig Technologies, Inc.
9.10. Biotronik
9.11. Coremap
9.12. EP Solutions Sa
9.13. Koninklijke Philips N.V.
9.14. Lepu Medical

10. Appendix
10.1. Discussion Guide
10.2. Author Details
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Abbott Laboratories
  • Biosense Webster, Inc.
  • Boston Scientific Corporation
  • Medtronic Plc
  • Microport Scientific Corporation
  • Acutus Medical
  • Angiodynamics
  • APN Health, LLC
  • Biosig Technologies, Inc.
  • Biotronik
  • Coremap
  • EP Solutions Sa
  • Koninklijke Philips N.V.
  • Lepu Medical
Note: Product cover images may vary from those shown
Adroll
adroll